Ovid Therapeutics appoints Meg Alexander as President and COO effective Sept 9

Ovid Therapeutics Inc.

Annual base salary of $500,000; target bonus of 45% of base salary.
Granted option to purchase 140,000 shares at $1.07 per share, 10-year term.
Option vests 25% on one-year anniversary, then monthly over 36 months.
Severance includes 12 months salary and COBRA gross-up on covered termination.
Alexander previously served as Chief Strategy Officer since June 2023.

item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Margaret "Meg" Alexander

President and Chief Operating Officer

OVID · Ovid Therapeutics Inc.

Effective: 2024-09-09
Filed: September 11, 2024, 7:59 PM ET

On September 8, 2024, the Board of Directors of Ovid Therapeutics Inc. (the “Company”) appointed Margaret “Meg” Alexander, the Company’s Chief Strategy Officer, to President and Chief Operating Officer (“COO”) of the Company, effective September 9, 2024.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Margaret "Meg" Alexander was appointed as President and Chief Operating Officer at Ovid Therapeutics Inc..

Action: appointed
Role: President and Chief Operating Officer

Exact text from the filing

On September 8, 2024, the Board of Directors of Ovid Therapeutics Inc. (the “Company”) appointed Margaret “Meg” Alexander, the Company’s Chief Strategy Officer, to President and Chief Operating Officer (“COO”) of the Company, effective September 9, 2024.

View on SEC.gov

Ovid Therapeutics Inc. filing history →

Source: SEC EDGAR

accession 0001193125-24-217302

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.